PreveCeutical Medical Inc. (CSE:PREV)

Revenue by Segment

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Licensing, Branding and Marketing Nutraceutical and Wellness Products						3.03K	15.45K	22.23K	31.05K
Licensing, Branding and Marketing Nutraceutical and Wellness Products Growth						-80.38%	-30.50%	-28.40%	-
Total						3.03K	15.45K	22.23K	31.05K
Total Growth						-80.38%	-30.50%	-28.40%	-

Revenue by Geography

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Canada						1.38K	5.68K	4.98K	18.73K
Canada Growth						-75.69%	14.15%	-73.43%	-
United States						1.65K	1.73K	6.21K	9.36K
United States Growth						-4.57%	-72.15%	-33.70%	-
Other						-	8.04K	11.05K	2.97K
Other Growth						-	-27.21%	272.68%	-
Total						3.03K	15.45K	22.23K	31.05K
Total Growth						-80.38%	-30.50%	-28.40%	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 1, 2026

Data Sources Report a data error